Sort
23,748 grants matching “melanoma”
The Cutaneous Biology of MAGE Transcription Factors
$160,847Jack B Longley · University Of Wisconsin-Madison · R21 · FY2013 · AR
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
$160,842Andrew K Godwin · University Of Kansas Medical Center · R01 · FY2022 · CA
Project 2: Molecular Approaches for Assessing Metastasis and Disease Relapse
$160,797Dave S B Hoon · Saint John'S Cancer Institute · P01 · FY2008 · CA
Administration, Evaluation and Planning Core
$160,738Thomas S. Kupper · Brigham And Women'S Hospital · P50 · FY2008 · CA
A Small Molecule to Activate Tumor Immunity after PLX403 in V600E BRAF Melanoma
$160,721Barry Jones · Arisaph Pharmaceuticals, Inc. · R41 · FY2014 · CA
Mechanisms of non-genetic variation in melanoma
$160,672Salil Garg · Yale University · K08 · FY2022 · CA
Informatics, Tissue Resource, and Pathology Core
$160,645Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Core B - Metabolomics
$160,598Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA
The regulation of melanocyte stem cells by Wnt signaling
$160,561Mayumi Ito · New York University School Of Medicine · R01 · FY2013 · AR
The role of Toll-like receptor 3 in overcoming cancer immunoediting
$160,459Jessica K Bell · Virginia Commonwealth University · K22 · FY2007 · CA
ACT 1: PROJ 3: MULTI-PHOTON & SECOND-HARMONIC GENERATION OPTICAL BIOPSY
$160,380Lily H Laiho · University Of Hawaii At Manoa · G12 · FY2007 · RR
SOMATIC NON-SYNONYMOUS MUTATIONS AS UNIQUE TUMOR ANTIGENS IN MELANOMA
$160,342Beatriz M. Carreno · Washington University · R21 · FY2014 · CA
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention
$160,335Rebecca Morris · University Of Arizona · P01 · FY2021 · CA
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
$160,333Peter Michael Bruno · University Of California, San Francisco · OT2 · FY2024 · CA
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma
$160,292Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Aptamer-Based Nanotechnology for Detection of Plasma Melanoma Markers
$160,288Gary A Clawson · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2010 · CA
Administrative Core
$160,206Jane Amanda Skok · New York University School Of Medicine · P01 · FY2022 · CA
Cancer and Leukemia Group B
$160,142Jeffrey None Crawford · Duke University · U10 · FY2007 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$160,114Jin-Ming Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · CA
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention
$160,007Rebecca Morris · University Of Arizona · P01 · FY2023 · CA
Protein Arginine Methylation in Chemotherapy Resistance
$160,001Wei Xu · University Of Wisconsin-Madison · R01 · FY2017 · CA
Protein Arginine Methylation in Chemotherapy Resistance
$160,001Wei Xu · University Of Wisconsin-Madison · R01 · FY2020 · CA
Protein Arginine Methylation in Chemotherapy Resistance
$160,001Wei Xu · University Of Wisconsin-Madison · R01 · FY2018 · CA
Protein Arginine Methylation in Chemotherapy Resistance
$160,001Wei Xu · University Of Wisconsin-Madison · R01 · FY2021 · CA
The role of the PI3K pathway in immune resistance
$160,000Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA